Lonza | LONN - Spese Di Vendita E Di Amministrazione





Spese Di Vendita E Di Amministrazione Cambiamento Data
Akzo Nobel EUR 833M 29M 2026-06
Alcon AG USD 964M 82M 2026-06
AstraZeneca USD 5.8B 735M 2026-06
BASF EUR 2.28B 156M 2026-06
Bayer EUR 3.96B 267M 2026-06
Beiersdorf EUR 271M 51M 2025-12
Covestro EUR 445M 8M 2025-12
Demant DKK 7.09B 1B 2026-06
Fresenius EUR 760M 17M 2026-06
Fresenius Medical Care EUR 736.01M 12.99M 2026-06
Geberit CHF 226M 38.6M 2025-03
Genmab DKK 205M 39M 2026-06
Givaudan CHF 561M 25M 2025-12
GlaxoSmithKline GBP 2.19B 75M 2026-06
GN Store Nord DKK 805M 42M 2026-06
Hikma Pharmaceutical USD 288M 149M 2025-12
Johnson Matthey GBP 119M 51M 2026-06
Merck EUR 1.57B 49M 2026-06
Novartis USD 3.24B 101M 2026-06
Philips EUR 1.21B 23M 2026-06
Roche Holding CHF 6.37B 908M 2026-06
Sanofi EUR 2.63B 307M 2026-06
Smith & Nephew USD 1.45B 29M 2026-06
Solvay EUR 123M 8M 2026-06
UCB EUR 1.47B 193M 2025-12